Company: PHAT
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057326
Chunk: 44

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 44
---
 of the executive compensation program for the individuals listed in the “Summary Compensation Table” below. For 2024, our named executive officers, or NEOs, are:

Terrie Curran, our former President and Chief Executive Officer;

Azmi Nabulsi, M.D., M.P.H., our Chief Operating Officer; and

Molly Henderson, our Chief Financial and Business Officer.

Effective April 1, 2025, Steven Basta was appointed as our President and Chief Executive Officer, replacing Ms. Curran who resigned as President and Chief Executive Officer, effective March 31, 2025.

Specifically, this section provides an overview of our executive compensation program and each compensation component that we provide. This discussion may contain forward-looking statements that are based on our current plans, considerations, expectations and determinations regarding future compensation programs. Actual compensation programs that we adopt following the date of this proxy statement may differ materially from the currently planned programs summarized in this discussion.

Our Executive Compensation Practices

We endeavor to maintain sound executive compensation policies and practices consistent with our executive compensation philosophy. The following table highlights some of our executive compensation policies and practices, which are structured to drive performance and align our executives’ interests with our stockholders’ long-term interests:

<div align='center'>29</div>

<div align='center'>30</div>

Summary Compensation Table The following table presents summary information regarding the total compensation that was awarded to, earned by, or paid to our NEOs for services rendered during the years ended December 31, 2024, and 2023.

| Name and Principal Position (as of December 31, 2024) | Year | Salary 
 ($)    |         |     | Bonus 
 ($)   |   |     | Stock  
 Awards 
 ($)(1) |           |     | Option 
 Awards 
 ($)(1) |           |     | Non-equity     
 Incentive Plan 
 Compensation   
 ($)(2)         |         |     | All Other    
 Compensation 
 ($)(3)       |        |     | Total 
 ($)   |           |
| Terrie Curran                                         | 2024 |        | 708,125 |     |       | — |     |        |         — |     |        | 2,471,283 |     |                | 368,225 |     |              | 17,250 |     |       | 3,564,883 |
| Former President and Chief Executive Officer          | 2023 |        | 687,